The Cataltheia Group and its U.S. subsidiary, Bruno Vision Care LLC, a leader in eye health innovation, today announced that the U.S. Food and Drug Administration (FDA) has cleared the first and only ...
Vision loss has long been treated as a one-way street, a devastating endpoint rather than a problem the brain might quietly work to solve. A wave of research is now overturning that assumption, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback